4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Sartorius Stedim Biotech S.A. (DIM) operates in the Medical Instruments & Supplies industry and is headquartered in Aubagne, France with about 10,477 employees. Its market capitalization is roughly €18 billion. In the fiscal year ended 2025-12-31, DIM reported €3.0B in revenue and €266M in net income.
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | €3.0B | €2.8B | €2.8B | €3.5B | — |
| Gross Profit | €1.3B | €1.2B | €1.2B | €1.8B | — |
| Operating Income (EBIT) | €539M | €398M | €471M | €1.1B | — |
| Net Income | €266M | €175M | €310M | €876M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | €766M | €762M | €772M | €745M | €745M | — |
| Gross Profit | €359M | €345M | €317M | €345M | €356M | — |
| Operating Income (EBIT) | €154M | €149M | €134M | €129M | €141M | — |
| Net Income | €93M | €88M | €47M | €68M | €86M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (€67M) | (€67M) | (€133M) | (€116M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Dividends Paid | — | — | €0M | — | — | — | €0M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €8.0B | €8.3B | €7.7B | €5.1B | — |
| Total Liabilities | €3.9B | €4.2B | €5.1B | €2.6B | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DIM viewer.
About TickerBase · Data methodology & sources · Privacy · Terms